• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CUV 0.45% $15.69

CLINUVEL PHARMACEUTICALS LIMITED

Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical... Clinuvel Pharmaceuticals Limited is an Australia-based global specialty pharmaceutical company. The Company is focused on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialized populations. Its lead therapy, SCENESSE (afamelanotide 16mg), is approved for commercial distribution in Europe, the USA, Israel, and Australia as the first systemic photoprotective drug for the prevention of phototoxicity (anaphylactoid reactions and burns) in adult patients with erythropoietic protoporphyria (EPP). The Company’s pharmaceuticals product development includes PRENUMBRA and NEURACTHEL. Its PhotoCosmetics product development includes CYACELLE and DNA Repair Assist and Melanogenesis. PRENUMBRA is a formulation of afamelanotide designed to provide a flexible dose in identified patient groups. NEURACTHEL is a novel formulation of the melanocortin adrenocorticotropic hormone (ACTH).More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CUV 14:50 35 12K
14:50 Last post  TheAnalyst007 Comments Created with Sketch.  35  Views Created with Sketch.  12K 
CUV
Shorts are trapped
14:17 20 5.3K
14:17 Last post  Melon felon! Comments Created with Sketch.  20  Views Created with Sketch.  5.3K 
CUV
Scenesse expanding to 4+ implants annually in the EU?
11:43 7 1.3K
11:43 Last post  ironbark222 Comments Created with Sketch.  7  Views Created with Sketch.  1.3K 
CUV
Time for a Change
25/05/24 2 728
25/05/24 Last post  Eagle0 Comments Created with Sketch.  2  Views Created with Sketch.  728 
CUV 24/05/24 0 381
24/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  381 
CUV
Fundies are Loading Up
24/05/24 10 2.4K
24/05/24 Last post  TheAnalyst007 Comments Created with Sketch.  10  Views Created with Sketch.  2.4K 
CUV
38 days to cover short positions = nice setup
24/05/24 6 1.7K
24/05/24 Last post  F18FDG Comments Created with Sketch.  6  Views Created with Sketch.  1.7K 
CUV
13% since March and uncorrelated to other holdings
24/05/24 2 709
24/05/24 Last post  TheAnalyst007 Comments Created with Sketch.  2  Views Created with Sketch.  709 

See All Discussions arrow Created with Sketch.

Timeline

Ceasing to be a substantial holder
24 May 18:06
 
CLINUVEL and Valentech enter Latin American partnership
23 May 09:57
 
Update - Notification of buy-back - CUV
14 May 09:07
 
Becoming a substantial holder
14 May 08:18
 
Update - Notification of buy-back - CUV
10 May 09:08
 
Update - Notification of buy-back - CUV
09 May 09:13
 
View More arrow Created with Sketch.
(20min delay)
Last
$15.69
Change
0.070(0.45%)
Mkt cap ! $786.1M
Open High Low Value Volume
$15.68 $15.98 $15.58 $1.543M 98.04K

Buyers (Bids)

No. Vol. Price($)
1 256 $15.61
 

Sellers (Offers)

Price($) Vol. No.
$15.77 256 1
View Market Depth
Last trade - 16.10pm 28/05/2024 (20 minute delay) ?
Last
$15.70
  Change
0.070 ( 0.36 %)
Open High Low Volume
$15.68 $15.97 $15.60 6072
Last updated 15.59pm 28/05/2024 ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.